中财网 中财网股票行情
复星医药(600196)财务分析指标    年份:
截止日期2026-06-302026-03-312025-12-312025-09-302025-06-30
营业总收入(万元)2044197.041007322.354166161.272939338.541951443.18
营业收入(万元)2044197.041007322.354166161.272939338.541951443.18
营业总成本(万元)1968262.80953229.524008732.512841559.561890436.25
营业成本(万元)1028818.86506673.932080010.321522546.241012346.51
净利润(万元)109350.2547866.34291415.07224246.28165985.77
归属于母公司的净利润(万元)172146.7787082.56337056.16252329.35170196.78
营业利润(万元)261594.11137537.62522835.13390676.54276120.84
利润总额(万元)258657.19135754.44511198.33383734.35271848.16
少数股东损益(万元)42746.0720880.2387736.8153279.8439824.28
基本每股收益(元)0.65(元)0.33(元)1.27(元)0.95(元)0.64(元)
稀释每股收益(元)0.65(元)0.33(元)1.27(元)0.95(元)0.64(元)
非经常性损益(万元)----------
扣除非经常性损益后净利润(万元)114416.5750053.24234016.05157324.3496078.65
总资产(万元)12542790.3112296638.8312005396.8911812073.8511882793.71
总负债(万元)6202598.015929703.925821361.915730913.865851282.87
归属于母公司股东权益合计(万元)4873119.354914674.484874150.704802850.294739762.37
股东权益合计(万元)6340192.306366934.916184034.996081159.996031510.84
实收资本(股本)(万元)267042.93267042.93267042.93267042.93267042.93
资本公积(万元)1630254.231630350.651637693.221633561.601628729.68
未分配利润(万元)2975038.122992916.512905833.962823379.932741251.86
经营活动产生的现金流量净额(万元)242395.24114859.78521322.69338176.86213400.05
经营活动现金流入小计(万元)2196964.951110489.274331541.873221208.112138899.35
经营活动现金流出小计(万元)1954569.71995629.493810219.182883031.251925499.30
投资活动产生的现金流量净额(万元)-442809.83-172928.45-214576.63-151183.24-85973.70
投资活动现金流入小计(万元)90729.3059029.03372225.87288801.18201266.35
投资活动现金流出小计(万元)533539.13231957.48586802.50439984.43287240.05
筹资活动产生的现金流量净额(万元)267600.40127819.52-324408.95-324442.66-146020.03
筹资活动现金流入小计(万元)1392923.87795335.813733401.942686931.481684856.79
筹资活动现金流出小计(万元)1125323.47667516.294057810.893011374.141830876.81
期末现金及现金等价物余额(万元)948726.72957694.80903801.01793613.25921527.55
最后修改日期2026-08-252026-04-282026-03-242025-10-282025-08-27
返回页顶

转至复星医药(600196)行情首页

中财网免费提供股票、基金、债券、外汇、理财等行情数据以及其他资料,仅供用户获取信息。